Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03907852
Title Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors TCR2 Therapeutics
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
University of California, San Francisco San Francisco California 94143 United States Details
University of Miami Sylvester Cancer Center Miami Florida 33136 United States Details
University of Chicago Medical Center Chicago Illinois 60637 United States Details
National Cancer Institute Bethesda Maryland 20814 United States Details
Columbia University Medical Center New York New York 10032 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Duke University Durham North Carolina 27705 United States Details
University of Pennsylvania Philadelphia Pennsylvania 19104 United States Details
SCRI Oncology Partners Nashville Tennessee 37203 United States Details
University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Princess Margaret Cancer Centre Toronto Ontario M5G 2C1 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field